United Therapeutics (UTHR) Misses Q1 EPS by 19c
Tweet
Share
E-mailGet Alerts UTHR Hot Sheet
Price: $538.30 +0.32%
Revenue Growth %: +1.5%
Financial Fact:
Research and development: 45.9M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: +1.5%
Financial Fact:
Research and development: 45.9M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q1 EPS of $3.02, $0.19 worse than the analyst estimate of $3.21. Revenue for the quarter came in at $369 million versus the consensus estimate of $397.42 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Sun Communities names Ileana McAlary as general counsel and EVP
- NVE Corporation names new CEO and expands board to seven members
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
